These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10366127)

  • 1. Plasma adrenomedullin in rheumatoid arthritis compared with other rheumatic diseases.
    Yudoh K; Matsuno H; Kimura T
    Arthritis Rheum; 1999 Jun; 42(6):1297-8. PubMed ID: 10366127
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte sedimentation rate within rheumatic disease clinics.
    Giacomello A; Quaratino CP; Zoppini A
    J Rheumatol; 1997 Nov; 24(11):2263-5. PubMed ID: 9375897
    [No Abstract]   [Full Text] [Related]  

  • 3. [The significance of the determination of mucoproteins and sialic acid in the blood serum for estimating the activity of rheumatism and rheumatoid arthritis].
    Kyrge KKh; Valgma KA; Poolak VI
    Vopr Revm; 1965; 5(4):29-33. PubMed ID: 5298237
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases.
    Oremek GM; Müller R; Sapoutzis N; Wigand R
    Anticancer Res; 2003; 23(2A):1131-4. PubMed ID: 12820360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked elevation of erythrocyte sedimentation rate in rheumatic disease.
    Adelizzi RA; Zarro VJ
    J Am Osteopath Assoc; 1980 May; 79(9):580-5. PubMed ID: 6966624
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis.
    Chosa E; Hamada H; Kitamura K; Eto T; Tajima N
    J Rheumatol; 2003 Dec; 30(12):2553-6. PubMed ID: 14719193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pepsin homoreactant (agglutinator) in patients with rheumatoid arthritis and other rheumatic diseases].
    Mirakhmedova AKh; Bartova LM; Tarkhanova IA; Kul'berg AIa; Trofimova TM
    Sov Med; 1977 Jul; (7):15-9. PubMed ID: 331491
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood viscosity in rheumatic diseases].
    Nasonova VA; Balabanova RM; Loskutova TT
    Revmatologiia (Mosk); 1984; (1):22-7. PubMed ID: 6371999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Viscosity and mechanical resistance of plasma in chronic rheumatic diseases].
    Litargini P; Berchiesi G; Favia RG
    Clin Ter; 1984 Jan; 108(1):49-58. PubMed ID: 6232042
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic value of examining basophilic leukocytes in the peripheral blood in rheumatism and rheumatoid arthritis].
    Moshchich VP
    Vrach Delo; 1983 Sep; (9):32-4. PubMed ID: 6606265
    [No Abstract]   [Full Text] [Related]  

  • 12. [The diagnostic significance of mucoproteins, sialic acid and cortisol in assessing the activity of rheumatic diseases].
    Paul R; Rotzsch W
    Z Gesamte Inn Med; 1989 Jul; 44(14):410-3. PubMed ID: 2815886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute phase and function in rheumatoid arthritis.
    Peri V; Rinaldi F
    J Rheumatol; 1998 Mar; 25(3):602-3. PubMed ID: 9517790
    [No Abstract]   [Full Text] [Related]  

  • 14. Levels of plasma total adrenomedullin are related with two acute phase inflammatory reactants (fibrinogen and sialic acid) but not with markers of endothelial dysfunction in Type 1 diabetes Adrenomedullin and vascular risk factors in Type 1 DM.
    García-Unzueta MT; Berrazueta JR; Pesquera C; Obaya S; Fernández MD; Sedano C; Amado JA
    J Diabetes Complications; 2005; 19(3):147-54. PubMed ID: 15866060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ABO and Gm(a) blood group systems in rheumatic diseases].
    Kruszewski K
    Przegl Lek; 1966; 22(9):608-10. PubMed ID: 5297029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the behavior of neuraminic acid in rheumatism and rheumatoid arthritis].
    Gebala A; Chwedoruk B
    Przegl Lek; 1969; 25(3):292-5. PubMed ID: 5305999
    [No Abstract]   [Full Text] [Related]  

  • 17. [Leukergy in various diseases of the locomotor apparatus].
    DANEO V; SECONDO G
    Reumatismo; 1953; 5(5):313-23. PubMed ID: 13167523
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis.
    Yamamoto T; Chikugo T; Tanaka Y
    Clin Rheumatol; 2002 Nov; 21(6):501-4. PubMed ID: 12447635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Content of DNA antibodies in the blood serum of patients with rheumatism and with infectious nonspecific (evolutive) polyarthritis].
    Zborovskiĭ AB; Skvortsova ZS
    Vopr Revm; 1972; 12(1):17-21. PubMed ID: 4537831
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of early rheumatoid arthritis.
    Brown AN
    J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.